- Home
- CNMD vs VCEL Comparison
CNMD vs VCEL Comparison
Compare CNMD & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- VCEL
- Stock Information
- Founded
- CNMD 1970
- VCEL 1989
- Country
- CNMD United States
- VCEL United States
- Employees
- CNMD N/A
- VCEL N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNMD Health Care
- VCEL Health Care
- Exchange
- CNMD Nasdaq
- VCEL Nasdaq
- Market Cap
- CNMD 1.5B
- VCEL 1.6B
- IPO Year
- CNMD 1987
- VCEL 1997
- Fundamental
- Price
- CNMD $46.71
- VCEL $34.88
- Analyst Decision
- CNMD Hold
- VCEL Strong Buy
- Analyst Count
- CNMD 5
- VCEL 6
- Target Price
- CNMD $59.80
- VCEL $58.60
- AVG Volume (30 Days)
- CNMD 314.1K
- VCEL 564.5K
- Earning Date
- CNMD 11-05-2025
- VCEL 11-06-2025
- Dividend Yield
- CNMD 1.71%
- VCEL N/A
- EPS Growth
- CNMD 12.82
- VCEL 2045.40
- EPS
- CNMD 3.54
- VCEL 0.13
- Revenue
- CNMD $1,326,244,000.00
- VCEL $249,119,000.00
- Revenue This Year
- CNMD $6.73
- VCEL $18.35
- Revenue Next Year
- CNMD $5.45
- VCEL $22.26
- P/E Ratio
- CNMD $13.19
- VCEL $261.17
- Revenue Growth
- CNMD 3.94
- VCEL 16.13
- 52 Week Low
- CNMD $42.50
- VCEL $29.24
- 52 Week High
- CNMD $78.00
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- CNMD 46.21
- VCEL 50.89
- Support Level
- CNMD $43.64
- VCEL $35.47
- Resistance Level
- CNMD $49.62
- VCEL $36.95
- Average True Range (ATR)
- CNMD 1.55
- VCEL 1.53
- MACD
- CNMD 0.39
- VCEL 0.20
- Stochastic Oscillator
- CNMD 59.07
- VCEL 62.69
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.